Skip to main content
. 2017 May 19;108(5):1007–1012. doi: 10.1111/cas.13230

Figure 1.

Figure 1

Tumor responses in individual patients classified according to the Revised Response Criteria for Malignant Lymphoma (evaluable patients, N = 13; efficacy data as assessed by a central review committee).